Infliximab for the treatment of intravenous immunoglobulin resistant Kawasaki disease complicated by coronary artery aneurysms: a case report.
This case report describes an 8 year old boy with IVIG resistant Kawasaki disease complicated by severe bilateral coronary artery aneurysms successfully treated with infliximab, a monoclonal antibody against tumour necrosis factor alpha.
Brogan
Robert J
RJ
Department of Paediatric Rheumatology, UCL Institute of Child Health and Great Ormond Street Hospital, 30 Guilford Street, London, UK. robbie.brogan@googlemail.com.
Eleftheriou
Despina
D
Gnanapragasam
James
J
Klein
Nigel J
NJ
Brogan
Paul A
PA